Market Closed -
Hong Kong S.E.
04:08:05 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
5.1
HKD
|
-.--%
|
|
-2.49%
|
-2.11%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,759
|
2,878
|
2,693
|
1,829
|
1,736
|
1,698
|
-
|
-
|
Enterprise Value (EV)
1 |
2,759
|
2,878
|
2,693
|
1,829
|
1,736
|
1,698
|
1,698
|
1,698
|
P/E ratio
|
-652
x
|
50.1
x
|
20.2
x
|
20.4
x
|
13.2
x
|
8.5
x
|
-
|
-
|
Yield
|
-
|
-
|
1.21%
|
1.14%
|
-
|
2.75%
|
-
|
-
|
Capitalization / Revenue
|
6.71
x
|
6.07
x
|
4.26
x
|
3
x
|
2.43
x
|
1.98
x
|
1.71
x
|
1.51
x
|
EV / Revenue
|
6.71
x
|
6.07
x
|
4.26
x
|
3
x
|
2.43
x
|
1.98
x
|
1.71
x
|
1.51
x
|
EV / EBITDA
|
21.3
x
|
15.2
x
|
10.1
x
|
8.57
x
|
6.18
x
|
5.18
x
|
4.21
x
|
3.58
x
|
EV / FCF
|
86.1
x
|
71.7
x
|
-
|
23.8
x
|
-
|
16.5
x
|
12
x
|
11.6
x
|
FCF Yield
|
1.16%
|
1.39%
|
-
|
4.21%
|
-
|
6.05%
|
8.32%
|
8.59%
|
Price to Book
|
2.77
x
|
3.02
x
|
2.67
x
|
1.8
x
|
-
|
1.29
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
329,234
|
329,234
|
329,234
|
333,240
|
333,240
|
332,940
|
-
|
-
|
Reference price
2 |
8.380
|
8.740
|
8.180
|
5.490
|
5.210
|
5.100
|
5.100
|
5.100
|
Announcement Date
|
3/25/20
|
3/16/21
|
3/23/22
|
3/28/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
411.4
|
473.8
|
632.9
|
610.3
|
714.3
|
858.4
|
994.2
|
1,126
|
EBITDA
1 |
129.7
|
189.2
|
265.9
|
213.5
|
280.9
|
328
|
403.3
|
474.7
|
EBIT
1 |
29.13
|
107.6
|
189.8
|
132.8
|
193.5
|
248.8
|
272.6
|
313.6
|
Operating Margin
|
7.08%
|
22.7%
|
29.99%
|
21.76%
|
27.09%
|
28.99%
|
27.42%
|
27.85%
|
Earnings before Tax (EBT)
1 |
20.41
|
98.65
|
195.7
|
129
|
190.6
|
247
|
271.9
|
307.9
|
Net income
1 |
-3.293
|
65.58
|
133.6
|
89.47
|
131.2
|
174.8
|
207.6
|
215.5
|
Net margin
|
-0.8%
|
13.84%
|
21.1%
|
14.66%
|
18.37%
|
20.36%
|
20.89%
|
19.14%
|
EPS
2 |
-0.0128
|
0.1746
|
0.4058
|
0.2693
|
0.3950
|
0.6000
|
-
|
-
|
Free Cash Flow
1 |
32.03
|
40.12
|
-
|
76.95
|
-
|
102.7
|
141.2
|
145.8
|
FCF margin
|
7.79%
|
8.47%
|
-
|
12.61%
|
-
|
11.96%
|
14.2%
|
12.95%
|
FCF Conversion (EBITDA)
|
24.7%
|
21.2%
|
-
|
36.04%
|
-
|
31.31%
|
35.01%
|
30.71%
|
FCF Conversion (Net income)
|
-
|
61.17%
|
-
|
86.01%
|
-
|
58.77%
|
68%
|
67.66%
|
Dividend per Share
2 |
-
|
-
|
0.0993
|
0.0627
|
-
|
0.1400
|
-
|
-
|
Announcement Date
|
3/25/20
|
3/16/21
|
3/23/22
|
3/28/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
32
|
40.1
|
-
|
77
|
-
|
103
|
141
|
146
|
ROE (net income / shareholders' equity)
|
9.78%
|
8.19%
|
14.1%
|
8.86%
|
-
|
17%
|
14.7%
|
14.8%
|
ROA (Net income/ Total Assets)
|
5.55%
|
5.66%
|
9.96%
|
6.15%
|
-
|
10.2%
|
9.6%
|
9.7%
|
Assets
1 |
-59.33
|
1,159
|
1,342
|
1,455
|
-
|
1,722
|
2,163
|
2,222
|
Book Value Per Share
2 |
3.030
|
2.900
|
3.060
|
3.040
|
-
|
3.950
|
-
|
-
|
Cash Flow per Share
2 |
-
|
0.2100
|
0.8300
|
0.6300
|
-
|
0.7200
|
-
|
-
|
Capex
1 |
27.9
|
38.3
|
44
|
56.3
|
-
|
75.8
|
68.9
|
66
|
Capex / Sales
|
6.79%
|
8.09%
|
6.95%
|
9.23%
|
-
|
8.83%
|
6.93%
|
5.86%
|
Announcement Date
|
3/25/20
|
3/16/21
|
3/23/22
|
3/28/23
|
3/28/24
|
-
|
-
|
-
|
Average target price
7.26
HKD Spread / Average Target +42.35% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.11% | 217M | | -23.90% | 2.81B | | -22.24% | 2.63B | | -49.80% | 2.59B | | -44.86% | 180M | | -32.40% | 115M |
Doctor's Office
|